This scenario has become more common with the widespread use of PSMA PET scans which enable earlier detection and delineation of oligometastatic PCa at much lower prostate-specific antigen (PSA) levels [1, 2]. This evidence concerns the gene KLK3 and posterior cortical atrophy.